Home » Stocks » ICUI

ICU Medical, Inc. (ICUI)

Stock Price: $203.11 USD -1.61 (-0.79%)
Updated Mar 3, 2021 3:59 PM EST - Market closed
After-hours: $202.90 -0.21 (-0.10%) Mar 3, 4:25 PM
Market Cap 4.30B
Revenue (ttm) 1.27B
Net Income (ttm) 86.87M
Shares Out 20.91M
EPS (ttm) 4.02
PE Ratio 50.52
Forward PE 26.11
Dividend n/a
Dividend Yield n/a
Trading Day March 3
Last Price $203.11
Previous Close $204.72
Change ($) -1.61
Change (%) -0.79%
Day's Open 204.09
Day's Range 200.01 - 206.57
Day's Volume 84,656
52-Week Range 158.01 - 236.50

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 6 days ago

SAN CLEMENTE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion thera...

GlobeNewsWire - 1 week ago

SAN CLEMENTE, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion thera...

GlobeNewsWire - 1 month ago

SAN CLEMENTE, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion thera...

The Motley Fool - 2 months ago

This medical device company is a vital part of the backbone of hospital products utilized in the U.S. and around the world.

Seeking Alpha - 3 months ago

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

ICU Medical (ICUI) delivered earnings and revenue surprises of 48.44% and 13.53%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 4 months ago

SAN CLEMENTE, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion thera...

GlobeNewsWire - 5 months ago

SAN CLEMENTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion th...

Zacks Investment Research - 6 months ago

ICU Medical (ICUI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Seeking Alpha - 6 months ago

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 6 months ago

SAN CLEMENTE, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion the...

PRNewsWire - 6 months ago

SAN CLEMENTE, Calif., Aug. 10, 2020 /PRNewswire/ -- ICU Medical Inc.

Zacks Investment Research - 7 months ago

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 7 months ago

SAN CLEMENTE, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion the...

PRNewsWire - 9 months ago

NEW YORK, June 2, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU" or "the ...

Seeking Alpha - 9 months ago

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Other stocks mentioned: EXPI, IIPR, PJT, ROCK
Seeking Alpha - 10 months ago

The best large-cap industries are electronic gaming, drugmakers, gold, packaged foods, and healthcare plans.

Other stocks mentioned: AKAM, AMZN, ATVI, BIIB, CNC, DXCM, EA, EQIX, HRL, JNJ, LOGM, MOH, NFLX, NTGR, RNG, SJM, VRTX, ZS
Zacks Investment Research - 11 months ago

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Other stocks mentioned: AWR, EXPI, SFL, UTI
Seeking Alpha - 1 year ago

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

ICU Medical (ICUI) delivered earnings and revenue surprises of 19.75% and 6.79%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 1 year ago

ICU Medical, Inc (ICUI) CEO Vivek Jain on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

ICU Medical (ICUI) delivered earnings and revenue surprises of 1.85% and 6.10%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 1 year ago

SAN CLEMENTE, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion th...

Zacks Investment Research - 1 year ago

ICU Medical, Inc. (ICUI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

Seeking Alpha - 1 year ago

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

ICU Medical (ICUI) delivered earnings and revenue surprises of -4.78% and 1.32%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 year ago

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

ICU Medical (ICUI) delivered earnings and revenue surprises of 18.35% and 4.13%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

ICU Medical (ICUI) could produce exceptional returns because of its solid growth attributes.

About ICUI

ICU Medical, together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and Ch... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Mar 31, 1992
CEO
Vivek Jain
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
ICUI
Full Company Profile

Financial Performance

In 2020, ICU Medical's revenue was $1.27 billion, an increase of 0.38% compared to the previous year's $1.27 billion. Earnings were $86.87 million, a decrease of -14.02%.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for ICU Medical stock is "Buy." The 12-month stock price forecast is 240.33, which is an increase of 18.33% from the latest price.

Price Target
$240.33
(18.33% upside)
Analyst Consensus: Buy